NovoCure NVCR
NASDAQ NVCR
$15.08 -0.84 (-5.28%)
As of: Oct 2, 2026 · 3:24 PM EDT

NovoCure (NVCR) Non Operating Interest Expenses (2014 - 2022)

Updated

NovoCure (NVCR) posted Non Operating Interest Expenses of $2.23 million for Q2 2022, up 137.0% from $940,000 a year earlier and up 30.4% from the prior quarter.

Analysis

NovoCure (NVCR) Non Operating Interest Expenses (2014 - 2022) Analysis & Trends

For the trailing twelve months through Jun 30, 2022, Non Operating Interest Expenses at NovoCure was $8.09 million, down 25.3% year-over-year; for FY2021, it came in at $7.74 million, down 37.1% from FY2020.

  • Annual Non Operating Interest Expenses shows a five-year compound annual growth rate of 1.1% (FY2016 to FY2021).
  • In prior years, NovoCure's Non Operating Interest Expenses was $12.3 million in FY2020 (+55.5%), $7.91 million in FY2019 (-35.5%), $12.27 million in FY2018 (+33.8%) and $9.17 million in FY2017 (+25.3%).
  • The Q2 2022 figure stands as the highest quarterly Non Operating Interest Expenses since Q1 2021.
  • On a year-over-year basis, Non Operating Interest Expenses increased in four of the last eight quarters, with growth averaging 13.2%.
  • The strongest year-over-year quarter for Non Operating Interest Expenses in the past five years was Q2 2022, with growth of 137.0%; the weakest was Q2 2021, with a decline of 64.1%.
  • According to Business Quant data, Non Operating Interest Expenses for the three prior quarters was $1.71 million (Q1 2022), $2.18 million (Q4 2021) and $1.98 million (Q3 2021).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Thermo Fisher Scientific 249.71 Bn 228.86 Bn 4.88 Bn 401.00 Mn
2 Abbott Laboratories 171.00 Bn 142.08 Bn 7.27 Bn 351.00 Mn
3 Danaher 155.79 Bn 139.61 Bn 3.61 Bn 107.00 Mn
4 Intuitive Surgical 143.91 Bn 123.46 Bn 1.96 Bn -
5 Medtronic 110.42 Bn 76.29 Bn 6.34 Bn 186.00 Mn
6 Stryker 105.71 Bn 91.82 Bn 4.50 Bn 141.00 Mn
7 Boston Scientific 63.26 Bn 58.27 Bn 3.85 Bn 96.00 Mn
8 Edwards Lifesciences 49.80 Bn 33.91 Bn 1.35 Bn -
9 Becton Dickinson 48.78 Bn 45.93 Bn 2.32 Bn 132.00 Mn
10 NovoCure 1.86 Bn -496.48 Mn 142.48 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2022 2.23 Mn
Mar 31, 2022 1.71 Mn
Dec 31, 2021 2.18 Mn
Sep 30, 2021 1.98 Mn
Jun 30, 2021 940,000.00
Mar 31, 2021 2.65 Mn
Dec 31, 2020 3.27 Mn
Sep 30, 2020 3.98 Mn
Jun 30, 2020 2.62 Mn
Mar 31, 2020 2.43 Mn
Dec 31, 2019 1.75 Mn
Sep 30, 2019 2.56 Mn
Jun 30, 2019 1.24 Mn
Mar 31, 2019 2.37 Mn
Dec 31, 2018 2.16 Mn
Sep 30, 2018 2.40 Mn
Jun 30, 2018 2.86 Mn
Mar 31, 2018 4.85 Mn
Dec 31, 2017 2.38 Mn
Sep 30, 2017 2.16 Mn
API Access

NovoCure Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=NVCR&period=max&api_key=YOUR_API_KEY